GlassScriptPhysician profile
Sherry Hsu
NPI 1740450956
$4,346.10
in general payments reported to CMS, 2019-2025
12 companies · $2,588 in 2025
The $2,588 reported for 2025 was more than what 95% of providers received nationally.
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $345 · 2020: $55.14 · 2021: $28.55 · 2022: $445 · 2023: $711 · 2024: $174 · 2025: $2,588.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Honoraria: $2,000 · Food and Beverage: $1,187 · Travel and Lodging: $286.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Honoraria | $2,000.00 |
| Food and Beverage | $1,186.90 |
| Travel and Lodging | $286.05 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Immunocore Limited | $2,762.05 | 2024-2025 | Kimmtrak |
| E.R. Squibb & Sons, L.L.C. | $568.54 | 2019-2023 | |
| Emd Serono, INC. | $282.60 | 2022-2023 | Bavencio |
| Astrazeneca Pharmaceuticals LP | $270.64 | 2019-2023 | |
| Genzyme Corporation | $133.93 | 2019 | |
| Abbvie INC. | $106.31 | 2021-2023 | |
| Jazz Pharmaceuticals INC. | $71.29 | 2023 | Zepzelca |
| Merck Sharp & Dohme LLC | $43.80 | 2019 | |
| Takeda Pharmaceuticals U.S.A., INC. | $32.36 | 2019 | |
| Agios Pharmaceuticals, INC. | $28.26 | 2019 | |
| Celgene Corporation | $27.39 | 2019 | |
| Kite Pharma, INC. | $18.93 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Sherry Hsu listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.